CIK 0001774857 · <br>Emerging growth company
Aardvark Therapeutics, Inc.
Sign in to watch- Ticker
- AARD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821606367
- Phone
- (858) 225-7696
- Business address
- 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $394,957
- in 1 filing, $395K under 10b5-1 plans
Net −$394,957. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-11 | Sun Nelson Chief Financial Officer | Purchase | +3,000 | $14.40 | $43K | 108,484 |
| 2025-12-11 | Lee Tien-Li Chief Executive Officer | Purchase | +7,000 | $14.49 | $101K | 1,551,613 |
| 2025-09-15 | Lee Tien-Li Chief Executive Officer | Purchase | +6,500 | $9.51 | $62K | 1,539,884 |
| 2025-09-15 | Lee Tien-Li Chief Executive Officer | Purchase | +3,500 | $9.94 | $35K | 1,543,384 |
| 2025-09-12 | Lee Tien-Li Chief Executive Officer | Purchase | +5,000 | $8.50 | $43K | 1,533,384 |
| 2025-09-11 | Lee Tien-Li Chief Executive Officer | Purchase | +6,000 | $7.82 | $47K | 1,528,384 |
| 2025-09-10 | Lee Tien-Li Chief Executive Officer | Purchase | +9,000 | $7.91 | $71K | 1,522,384 |
| 2025-09-09 | Sun Nelson Chief Financial Officer | Purchase | +6,000 | $8.07 | $48K | 105,484 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. 10% owner | Purchase | +625,000 | $16.00 | $10.0M | 2,958,887 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. 10% owner | Purchase | +625,000 | $16.00 | $10.0M | 958,412 |
| 2025-02-14 | Lee Tien-Li Chief Executive Officer | Purchase | +16,542 | $16.00 | $265K | 1,496,175 |
| 2025-02-14 | Sun Nelson Chief Financial Officer | Purchase | +10,000 | $16.00 | $160K | 99,484 |
| 2025-02-14 | Cormorant Asset Management, LP Former 10% Owner | Purchase | +187,500 | $16.00 | $3.0M | 987,689 |
Page 1 of 1 · 13 trades